Our kinase assay development services are designed to support the discovery and evaluation of kinase inhibitors, which are critical in drug discovery, particularly for cancer and other diseases involving dysregulated signaling pathways. The assay is a luminescence-based method that measures kinase activity by quantifying ADP production during the phosphorylation process. This assay is highly sensitive, allowing for the detection of even low levels of kinase activity and facilitating the identification of potent inhibitors. With our expertise in assay design, optimization, and validation, we provide robust solutions for high-throughput screening and lead optimization in kinase inhibitor development.
Quick Contact
If you have any questions or need help, feel free to contact with our team.
Send Us Email:
English